AIM ImmunoTech Inc (AIM)
0.262
+0.02
(+8.26%)
USD |
NYAM |
Nov 14, 16:00
0.247
-0.02
(-5.73%)
After-Hours: 20:00
AIM ImmunoTech Gross Profit (Annual): 0.16M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.16M |
| December 31, 2022 | 0.141M |
| December 31, 2021 | -0.715M |
| December 31, 2020 | -0.643M |
| December 31, 2019 | -0.753M |
| December 31, 2018 | -0.517M |
| December 31, 2017 | -0.746M |
| December 31, 2016 | -1.016M |
| December 31, 2015 | -1.465M |
| December 31, 2014 | -1.054M |
| December 31, 2013 | -1.084M |
| December 31, 2012 | -1.776M |
| December 31, 2011 | -0.882M |
| December 31, 2010 | -1.206M |
| December 31, 2009 | -0.473M |
| Date | Value |
|---|---|
| December 31, 2008 | -0.533M |
| December 31, 2007 | 0.129M |
| December 31, 2006 | -0.342M |
| December 31, 2005 | 0.692M |
| December 31, 2004 | -0.883M |
| December 31, 2003 | 0.155M |
| December 31, 2002 | |
| December 31, 2001 | |
| December 31, 2000 | 1.275M |
| December 31, 1999 | 0.997M |
| December 31, 1998 | 0.701M |
| December 31, 1997 | 0.50M |
| December 31, 1996 | 0.20M |
| December 31, 1995 | 3.30M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
-0.753M
Minimum
2019
0.16M
Maximum
2023
-0.362M
Average
-0.643M
Median
2020
Gross Profit (Annual) Benchmarks
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 42.51M |
| Electromed Inc | 41.73M |
| Xtant Medical Holdings Inc | 55.47M |
| Armata Pharmaceuticals Inc | -- |